Latest filing published 05 Mar 2025 for Harmony Biosciences Holdings, Inc., €38k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Jeffrey Dierks on record concern Harmony Biosciences Holdings, Inc., in the capacity of senior executive. In total, 68 filings cover trades dated from 15 June 2021 to 3 March 2025.
The open-market record consists of 38 sales worth €11.0M, with no purchase. The rest of the record consists of 2 share grants and 28 option exercises. In 2025 alone, the filings show no purchases and 9 sales.
The latest filing, published on 5 March 2025, reports an open-market sale of €16k in Harmony Biosciences Holdings, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
24 of 24 declarations